If you or someone close to you has been diagnosed with cancer, you know how overwhelming it can feel. Genetic Cancer Screen Association (GCSA) is here to help. We are a company made up of doctors, genetic counselors along with other highly trained and experienced professionals that are committed to providing genomic insights to help you understand you and your family's genetic predisposition to cancer, as well as help your doctor guide your care and manage your genetic risks.
If you would like to learn more about the genetic cancer testing services we provide, use the section links below to learn more. You can also find answers to commonly asked questions. If you'd like to reach out for more information, please contact us.
Watch this video for an easy-to-understand overview on the basics of cancer and common treatment options.
The more information you have, the better prepared you'll be to talk with a physician and help make informed decisions for your best interests and optimal health outcome.
Cancer is often treated with chemotherapy, which tries to kill any fast-growing cells — sometimes killing healthy cells in the process. Drugs called targeted therapies and immunotherapies can more carefully select the cells they kill, making it easier to stop only the cells with mutations, and leaving healthy cells to grow normally.
By using comprehensive genomic profiling to identify the mutations in your cancer, your doctor can determine if a targeted therapy or immunotherapy may work, and which one to select for you.
The implementation of PGX testing helps physicians make informed treatment decisions. This will lead to better outcomes by decreasing adverse drug events and by increasing the effectiveness of drugs.
This approach to treatment is called precision medicine or personalized medicine, because it is based on your own unique genomic profile and cancer type. Our PGx profile provides accurate and reliable details on how your body metabolizes medications and suggests alternative prescriptions when increased sensitivity or reduced response is likely.
We are committed to delivering high-quality, affordable testing, to everyone who can benefit from it.
Our billing and reimbursement services are designed to make genetic testing accessible to patients regardless of their financial situation. Depending on the specific test, you may already have coverage through Medicare or private insurance.
For many patients who meet the medical necessity for testing, CGX and PGX is covered by Medicare at no cost.
If you are a Medicare recipient and you meet the following criteria, you may not have out-of-pocket expenses for your genetic cancer testing:
You have Original/Traditional Medicare [Part B] reflecting on your insurance card.
You have either existing, recurrent, relapsed, refractory, metastatic, or advanced stages III or IV cancer. OR you have a family ancestry or history of specific or rare cancers that may put you at higher risk than the normal population for developing cancer;
This is your first time having a CGX or PGX test for this cancer diagnosis OR you had a test before, but this is a different type of cancer—a “new primary” cancer diagnosis; and
Your test is ordered by one of our physicians.
We provide our patients with a comprehensive report of genetic variants and risk factors, so they understand their risk of developing cancer. We are able to search for specific genetic variants that put one at an increased risk of Hereditary Cancer, by analyzing a person's DNA and by using the latest advances in Next Generation Sequencing (NGS).
Sample CGX Report
Sample PGx Report
Tests We Offer
We are a leading provider in revolutionary lab tests for Cancer Genomic testing (CGx) and Pharmacogenomics testing (PGx). Testing for an industry leading 39 relevant genetic markers, we are able to partner with a patient’s physician to provide knowledge through our testing profiles, of potential health risks and diagnosis to guide healthcare as part of a patient’s clinical care (e.g., for diagnostic or therapeutic decision-making).
The ordering physician, with support provided by our genetic counselors, are able to formulate a treatment protocol to address any positive, negative or variant findings, which include, but are not limited to: recommendations for follow up with the patient's local physician for additional testing and/or monitoring. Awareness of one's risk factors allows patients and their physicians to take proactive approaches to help maintain a patient’s health and/or manage identified risks.
If needed, you may click on each test explanation to enlarge it.